Overview

Evaluating Safety and Efficacy of Cannabis in Participants With Chronic Posttraumatic Stress Disorder

Status:
Completed
Trial end date:
2019-03-22
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of vaporized cannabis in participants with chronic, treatment-resistant posttraumatic stress disorder.
Phase:
Phase 2
Details
Lead Sponsor:
Tilray
Collaborator:
University of British Columbia
Treatments:
Dronabinol